Out of Africa: Increasing reports of artemether-lumefantrine treatment failures of uncomplicated <i>Plasmodium falciparum</i> infection
Eric S. Halsey, Mateusz M. Pluciński
Abstract
Studies of travellers returning from Africa with uncomplicated Plasmodium falciparum infection are starting to provide signals of failure of artemether-lumefantrine, a first-line treatment of uncomplicated malaria. Traveller-based reports offer an important adjunct to antimalarial efficacy studies performed in endemic regions.
Topics & Concepts
Artemether/lumefantrineMedicineArtemetherPlasmodium falciparumMalariaLumefantrineFirst lineFirst line treatmentIntensive care medicineInternal medicineArtemisininImmunologyChemotherapyMalaria Research and ControlMosquito-borne diseases and controlTravel-related health issues